Ninepoint Partners LP Invests $1 Million in Aemetis, Inc (AMTX)
Ninepoint Partners LP purchased a new position in Aemetis, Inc (NASDAQ:AMTX) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,151,373 shares of the specialty chemicals company’s stock, valued at approximately $1,002,000. Ninepoint Partners LP owned about 5.81% of Aemetis as of its most recent SEC filing.
Separately, Geneva Advisors LLC increased its stake in Aemetis by 3.4% in the second quarter. Geneva Advisors LLC now owns 1,562,431 shares of the specialty chemicals company’s stock valued at $2,078,000 after purchasing an additional 50,800 shares during the last quarter. Hedge funds and other institutional investors own 18.71% of the company’s stock.
AMTX has been the subject of several analyst reports. Zacks Investment Research upgraded Aemetis from a “sell” rating to a “hold” rating in a research note on Thursday, July 20th. FBR & Co reissued a “neutral” rating and set a $2.00 price target on shares of Aemetis in a research report on Saturday, August 19th. Finally, B. Riley reissued a “hold” rating and set a $2.00 price target on shares of Aemetis in a research report on Monday.
Aemetis, Inc (AMTX) traded down $0.02 during mid-day trading on Friday, reaching $0.67. The company’s stock had a trading volume of 36,300 shares, compared to its average volume of 50,084. Aemetis, Inc has a 1 year low of $0.53 and a 1 year high of $2.50. The company has a quick ratio of 0.20, a current ratio of 0.37 and a debt-to-equity ratio of -1.87.
Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.
Receive News & Stock Ratings for Aemetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc and related stocks with our FREE daily email newsletter.